Fig 4 - حسب Maha Rehman (17114332)

Study-related adverse events. حسب Benjamin R. Lewis (22279166)

"…Safety was a study outcome and assessed by rate and severity of AEs and any incident suicidality or significant mental health symptoms. Baseline and outcome data were summarized using descriptive statistics, with continuous variables reported as means and standard deviations. …"

Study flow chart. حسب Benjamin R. Lewis (22279166)

"…Safety was a study outcome and assessed by rate and severity of AEs and any incident suicidality or significant mental health symptoms. Baseline and outcome data were summarized using descriptive statistics, with continuous variables reported as means and standard deviations. …"

Study CONSORT diagram. حسب Benjamin R. Lewis (22279166)

"…Safety was a study outcome and assessed by rate and severity of AEs and any incident suicidality or significant mental health symptoms. Baseline and outcome data were summarized using descriptive statistics, with continuous variables reported as means and standard deviations. …"

Baseline characteristics of the study sample^βμ. حسب Osama Mohamed Ibrahim (12006954)

"…Pharmacists in Active Group A (37.2%) and Active Group B (32.3%) most commonly intervened by recommending the cessation of medication, while the most common intervention in the Control Group was recommending a decrease in dose (29.8%). The mean cost reduction per patient was highest in Active Group A (31.3 ±11.8 $), followed by Active Group B (20.8 ±8.6 $) and the Control Group (19.6 ±9.5 $). …"

The flow diagram of the study (CONSORT, 2010). حسب Osama Mohamed Ibrahim (12006954)

"…Pharmacists in Active Group A (37.2%) and Active Group B (32.3%) most commonly intervened by recommending the cessation of medication, while the most common intervention in the Control Group was recommending a decrease in dose (29.8%). The mean cost reduction per patient was highest in Active Group A (31.3 ±11.8 $), followed by Active Group B (20.8 ±8.6 $) and the Control Group (19.6 ±9.5 $). …"

The concentration of inflammatory parameters (TNF-α and IL-10) in serum (a and b) and burned skin samples (c) of different experimental groups on day 2 and 10. حسب Omid Mehrpour (9385929)

Serum concentrations of malondialdehyde (a) and super oxide dismutase (b) and NOx (nitrate +nitrite) (c) in different experimental groups on day 2 and 10. حسب Omid Mehrpour (9385929)

The concentrations of malondialdehyde (a), super oxide dismutase (b), and NOx (nitrate +nitrite)(c) in the burned skin samples of different experimental groups on day 2 and 10. حسب Omid Mehrpour (9385929)

Renal (urea and creatinine) (a, b) and Liver function (ALT and AST) (c, d) test in serums of different experimental groups and body weight changes (e) on day 10. حسب Omid Mehrpour (9385929)

Phenotypic characterization of 81-week-old NMIIC KO mice. حسب Hiroki Hamaguchi (22783780)

Spontaneous physical activity and respiratory quotient (RQ) in WT and NMIIC KO mice. حسب Hiroki Hamaguchi (22783780)

Comparison of W_max (A), the changes in V_E (B), and W_VT (C) among the three oxygen conditions. حسب Kazufumi Hisamoto (21416905)

Fiber types and muscle force in the soleus of 18-20-week-old WT and NMIIC KO mice. حسب Hiroki Hamaguchi (22783780)

Evaluation of mitochondrial protein expression and morphology in NMIIC KO mice. حسب Hiroki Hamaguchi (22783780)

Expression of non-muscle myosin (NM) IIC in skeletal muscle cells. حسب Hiroki Hamaguchi (22783780)

Measurement of inflammatory cytokines in liver and heart tissues. حسب Ayça Toprak-Semiz (22582110)

Comparison of SpO₂ (A), HR (B), SBP (C), and DP (D) on VT among the three oxygen conditions. حسب Kazufumi Hisamoto (21416905)

Comparison of soleus muscle weight and fiber size histogram between young and aged WT and NMIIC KO mice. حسب Hiroki Hamaguchi (22783780)

NMIIC expression and muscle weight in the soleus of 82-86-week-old mice. حسب Hiroki Hamaguchi (22783780)